Related Experiment Video
Updated: Aug 13, 2026

Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation
Published on: March 5, 2018
Mechanism of XIAP-mediated inhibition of caspase-9
Eric N Shiozaki1, Jijie Chai, Daniel J Rigotti
1Department of Molecular Biology, Lewis Thomas Laboratory, Princeton University, Princeton, NJ 08544, USA.
Abstract:
The inhibitor of apoptosis (IAP) proteins potently inhibit the catalytic activity of caspases. While profound insight into the inhibition of the effector caspases has been gained in recent years, the mechanism of how the initiator caspase-9 is regulated by IAPs remains enigmatic. This paper reports the crystal structure of caspase-9 in an inhibitory complex with the third baculoviral IAP repeat (BIR3) of XIAP at 2.4 A resolution. The structure reveals that the BIR3 domain forms a heterodimer with a caspase-9 monomer. Strikingly, the surface of caspase-9 that interacts with BIR3 also mediates its homodimerization. We demonstrate that monomeric caspase-9 is catalytically inactive due to the absence of a supporting sequence element that could be provided by homodimerization. Thus, XIAP sequesters caspase-9 in a monomeric state, which serves to prevent catalytic activity. These studies, in conjunction with other observations, define a unified mechanism for the activation of all caspases.
Insights
Inhibitor of apoptosis proteins regulate caspases. This study reveals XIAP sequesters caspase-9 as a monomer, preventing its activity and defining a unified caspase activation mechanism.
Area of Science:
- Cellular biology
- Biochemistry
- Structural biology
Background:
- Inhibitor of apoptosis (IAP) proteins regulate caspase activity.
- The precise mechanism of initiator caspase-9 inhibition by IAPs is not fully understood.
Purpose of the Study:
- To elucidate the structural basis of caspase-9 inhibition by XIAP.
- To define the mechanism by which XIAP regulates caspase-9 activity.
Main Methods:
- X-ray crystallography to determine the structure of the caspase-9/XIAP-BIR3 complex.
- Biochemical assays to assess caspase-9 catalytic activity.
Main Results:
- The crystal structure of caspase-9 in complex with XIAP's BIR3 domain was determined at 2.4 A resolution.
- XIAP's BIR3 domain forms a heterodimer with monomeric caspase-9.
- The interaction surface between caspase-9 and BIR3 is also involved in caspase-9 homodimerization.
- Monomeric caspase-9 is catalytically inactive due to the lack of a homodimerization-dependent supporting element.
Conclusions:
- XIAP inhibits caspase-9 by sequestering it in an inactive monomeric state.
- This mechanism provides insight into the regulation of initiator caspases.
- A unified mechanism for the activation of all caspases is proposed.
Related Concept Videos
CRISPR
Apoptosis
Caspases
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
CRISPR/Cas9 Genome Editing

